Clomiphene Citrate Tablet
Product Images NDC 72888-213

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clomiphene Citrate (NDC 72888-213). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Clomipehe Citrate Tablets 50mg Carton)

This text is about Clomiphene Citrate Tablets USP, with each tablet containing 50mg of clomiphene citate. The usual dose is 1 tablet daily for 5 days. It provides information for pharmacists to dispense the tablets in a light-resistant container with a child-resistant closure, and to store the tablets at a controlled room temperature. The product is distributed by Advagen Pharma Ltd. in East Windsor, NJ, USA, and manufactured by Rubicon Research Private Limited in India. The product label includes the name "clomiPHENE Citrate Tablets USP" and indicates that it contains 30 tablets with 50mg per tablet, available by prescription only.*

FDA Label Image

Image Description (Clomipehe Citrate Tablets 50mg Foil)

FDA Label Image

Image Description (Clomipehe Citrate Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.